Home » Newsletters » BioWorld MedTech

BioWorld MedTech

Oct. 8, 2015

View Archived Issues

Medtronic's Salditt: expertise in combo products in short supply

Digital trends,new players change funding ballgame

Caught 'off Guard': Exact Sciences stock plunges on USPSTF recommendation

Australia's high court rules against Myriad

Regulatory Update: Heartflow receives 50th patent for FFRCT analysis system

Agreements/contracts: Myriad Genetics' Prolaris now covered by Tufts Health Plan

product briefs

Briefly noted

Patent Watch

MDD's Orthopedics Extra

Senate Appropriations subcommittee recommends $2B more: Increased NIH funding: There's a will, but is there a way?

No one seems to disagree that the NIH needs more funding. But finding a way to do that could prove tricky. Read More

CMS's Jensen: evidence-based payment may help EAP program

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...